Krensavage Asset Management, LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001609251

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q1 2025 · 14 positions · Total reported value $180.88M · Top-10 concentration 90.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 20.0% · 0 new · 2 cut · 2 exited

Active Share (vs S&P 500): 99.6% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +6.8% · vs SPY -8.0% · Prev Value $255.70M — last quarter positions weighted by this quarter price moves · ranking

In its Q1 2025 13F filing, Krensavage Asset Management, LLC disclosed 14 equity positions with a combined reported value of $180.88M. The filing implies a focused portfolio: its ten largest positions account for 90.1% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2025 were EXEL ($32.44M), UTHR ($30.28M), CAH ($26.00M). By sector, the heaviest allocations are Health Care 95.8%, Other 4.2%. Versus the prior quarter, allocation shifted toward Other (+4.0pp) and away from Health Care (-4.0pp).

Versus the prior quarter, Krensavage Asset Management, LLC opened 0 new positions, trimmed 2 and fully exited 2, a turnover rate of 20.0% of positions. The portfolio's overlap with the prior quarter was 73% of names.

The largest new positions opened in Q1 2025 were SUPN ($14.15M), GSK ($10.54M), AVDL ($7.44M).

Of the 2 positions fully exited versus the prior quarter, the largest were BIIB ($16.66M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2025)

  • SUPN SUPERNUS PHARMACEUTICALS · $14.15M
  • GSK GSK PLC · $10.54M
  • AVDL AVADEL PHARMACEUTICALS PLC · $7.44M

Fully Exited (vs previous quarter)

Insider Transactions (Form 4)

Latest Krensavage Asset Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Krensavage Asset Management, LLC, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 18 positions worth $263.22M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-78631 (status: Approved), registered 2013-10-04
  • Regulatory AUM (Form ADV): $300.23M as of 2026-03-25
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds

Portfolio Structure

  • 18 positions · $263.22M reported value (Q2 2026)
  • Top 10 holdings = 89.4% of reported value
  • Largest position: ENTA (ENANTA PHARMACEUTICALS INC COM) at 15.9%
  • Average position size: $14.62M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 4 added, 2 reduced, 2 exited
  • 12 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 95.8%
Other 4.2%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 878.53K $32.44M 17.93%
17.93%
Reduce
2 98.23K $30.28M 16.74%
16.74%
Add
3 188.75K $26.00M 14.38%
14.38%
Reduce
4 431.99K $14.15M 7.82%
7.82%
New
5 100.70K $12.50M 6.91%
6.91%
Reduce
6 2.12M $11.68M 6.46%
6.46%
Hold
7 272.00K $10.54M 5.83%
5.83%
New
8 965.37K $9.20M 5.09%
5.09%
Add
9 149.10K $8.27M 4.57%
4.57%
Hold
10 87.56K $7.97M 4.41%
4.41%
Reduce
11 950.00K $7.44M 4.11%
4.11%
New
12 207.82K $6.86M 3.79%
3.79%
Reduce
13 754.38K $3.46M 1.91%
1.91%
Add
14 70.26K $89.00K 0.05%
0.05%
Hold

FAQ

What did Krensavage Asset Management, LLC buy in 2025-Q1?

In its 2025-Q1 13F filing, Krensavage Asset Management, LLC reported 14 equity positions worth $180.88M in aggregate; its largest disclosed positions were EXEL ($32.44M), UTHR ($30.28M), CAH ($26.00M).

How large is Krensavage Asset Management, LLC's portfolio?

Krensavage Asset Management, LLC reported $180.88M of long equity holdings across 14 positions as of 2025-Q1. Top-10 holdings account for 90.1% of reported value.

What is Krensavage Asset Management, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/krensavage-asset-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →